Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol

被引:73
作者
Rusert, P
Fischer, M
Joos, B
Leemann, C
Kuster, H
Flepp, M
Bonhoeffer, S
Günthard, HF
Trkola, A
机构
[1] Univ Zurich Hosp, Div Infect Dis, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Hosp Epidemiol, CH-8091 Zurich, Switzerland
[3] ETH, Inst Ecol, CH-8092 Zurich, Switzerland
关键词
HIV; plasma viremia; infectious titer; virus isolation;
D O I
10.1016/j.virol.2004.05.022
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Methods currently used for HIV-1 viral load measurements are very sensitive, but cannot distinguish between infectious and noninfectious particles. Here we describe the development of a novel, sensitive, and highly reproducible method that allows rapid isolation and quantification of infectious particles from patient plasma. By immobilizing HIV-1 particles inhuman plasma to platelets using polybrene, we observed a 10-to 1000-fold increase in infectivity over infection protocols using free virus particles. Using this method, we evaluated infectivity in plasma from 52 patients at various disease stages. At plasma viral loads of 1000-10000 HIV-1 RNA copies/ml 18%, at 10000-50000 copies/m173%, at 50000-100000 copies/ml 90%, and above 100 000 copies 96% of cultures were positive. We found that infectious titers among patients vary distinctively but are characteristic for a patient over extended time periods. Furthermore, we demonstrate that by evaluating infectious titers in conjunction with total HIV RNA loads, subtle effects of treatment intervention on viremia levels can be detected. The immobilization procedure does not interfere with viral entry and does not restore the infectivity of neutralized virus. Therefore, this assay system can be utilized to investigate the influence of substances that specifically affect virion infectivity such as neutralizing antibodies, soluble CD4, or protease inhibitors. Measuring viral infectivity may thereby function as an additional, useful marker in monitoring disease progression and evaluating efficacy of antivirals in vivo. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:113 / 129
页数:17
相关论文
共 72 条
[11]  
Dictor M, 2001, SCAND J INFECT DIS, V33, P27, DOI 10.1080/003655401750064031
[12]  
*DIV AIDS, 1997, VIR MAN HIV LAB
[13]   Role of chondroitin 4-sulphate as a receptor for polycation induced human platelet aggregation [J].
Donato, JL ;
Marcondes, S ;
Antunes, E ;
Nogueira, MD ;
Nader, HB ;
Dietrich, CP ;
Rendu, F ;
deNucci, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 (07) :1447-1453
[14]   PLASMA VIREMIA TITRATION AND RNA QUANTITATION IN ICD-P24 NEGATIVE HIV TYPE-1-INFECTED PATIENTS [J].
ERCOLI, L ;
SARMATI, L ;
ELSAWAF, G ;
COCHI, S ;
LANTI, T ;
IUDICONE, P ;
GUGLIELMETTI, M ;
GIANNINI, G ;
GALLUZZO, C ;
TOMINO, C ;
ANDREONI, M ;
VELLA, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (10) :1203-1207
[15]   PLASMA VIREMIA AS A MARKER OF VIRAL REPLICATION IN HIV-INFECTED INDIVIDUALS [J].
ESCAICH, S ;
RITTER, J ;
ROUGIER, P ;
LEPOT, D ;
LAMELIN, JP ;
SEPETJAN, M ;
TREPO, C .
AIDS, 1991, 5 (10) :1189-1194
[16]   Attenuated and nonproductive viral transcription in the lymphatic tissue of HIV-1-infected patients receiving potent antiretroviral therapy [J].
Fischer, M ;
Joos, B ;
Wong, JK ;
Ott, P ;
Opravil, M ;
Hirschel, B ;
Weber, R ;
Günthard, HF .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (02) :273-285
[17]  
Fischer M, 2003, ANTIVIR THER, V8, P97
[18]   Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity [J].
Fortin, JF ;
Cantin, R ;
Lamontagne, G ;
Tremblay, M .
JOURNAL OF VIROLOGY, 1997, 71 (05) :3588-3596
[19]  
Funk GA, 2001, J ACQ IMMUN DEF SYND, V26, P397, DOI 10.1097/00126334-200104150-00001
[20]  
Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31